NECTA
@nectansw
NSW Early Phase Clinical Trials Alliance (Australia)
ID: 1096022596225650688
http://www.necta.org.au 14-02-2019 12:25:24
107 Tweet
99 Followers
139 Following
Following success of #NOMP23 National Onc Mentorship Program in ⬇️ burnout, 🔼 professional fulfilment, excited to be launching #NOMP24 in conjunction with Medical Oncology Group of Australia Annual Meeting In Sydney. EOIs now open to any 🇦🇺 oncologist! Udit Bethan Richards
Phase 1/drug development triallist buddies from 3 continents 🇦🇺🇭🇰🇬🇧 #ASCO24 Herbert Loong, MBBS, FASCO Kai-Keen Shiu Natalie Cook 💙
Anthony M. Joshua, MBBS, PhD, on Low-Risk Prostate Cancer and Metformin: New Trial Data ascopost.com/videos/2024-as… #pcsm #prostatecancer #oncology #ASCO24 ONCODOC University Health Network Princess Margaret Cancer Centre Research neil fleshner
A team effort with Anuradha Vasista Lauren B Belinda Kiely et al 📝 🙌 simple multiples of the median OS from RCTs can be used to estimate and communicate #prognosis for patients with advanced breast cancer starting endocrine therapy doi.org/10.1111/ajco.1… 🧵 1/X
Young Oncologist Members! Friday COB is the deadline to apply for one of 3 travel grants for ESMO Asia Congress 2024 in Singapore on 6-8 December. Includes registration, 3 nights accommodation and 750 EUR towards flights. moga.org.au/all-news/esmoa… ausyoungoncs
‼️📝New Journal of Clinical Oncology publication co-authored by John Park👨🏻⚕️🇦🇺 Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a HER2–Directed Antibody-Drug Conjugate, in HER2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I trial MQ University Clinical Trials Unit ➡️ ascopubs.org/doi/10.1200/JC… 🧵1/X
Here we go again - barely unpacked after #ASCO24 - ✈️ to Munich 🇩🇪 for inaugural #ESMOGI24 - looking forward to the program, networking and of course some 🍻🥨🍖!!! See you soon Megan Barnet Kai-Keen Shiu Thx for great program Ducreux Michel Teresa Macarulla and EricVanLeuven🌟
Registrations for #MOGA24 are open! 👉 moga.org.au/2024-asm the ASM this year in Sydney will feature a fantastic YOGA program: “Precision Medicine for Young Oncologists: What You Need to Know” 🇦🇺 👨⚕️👩⚕️Medical Oncology Group of Australia ausyoungoncs Omico Australia NECTA
Analysis from SPOTLIGHT and GLOW showing that Claudin 18.2 is a universal biomarker across 🌎 prevalent in 38%, similar regardless of tumor origin, collection method or site. 🌟Important for claudin 🎯- mAb, ADCs and CAR-Ts. 🌟routine🔬testing needed! Manish A. Shah + team 👏
The CLDN18.2–targeted ADC IBI343 was safe and showed efficacy signals in patients with pretreated, advanced gastric/GEJ adenocarcinoma with moderate to high CLDN18.2 expression. Jia (Jenny) Liu The Kinghorn Cancer Centre University of Sydney Saint Vincent Hospital ESMO - Eur. Oncology #oncology onclive.com/view/ibi343-is…
This week we had a fascinating chat with Dr Paul Kelly, Aus 'physician-investor'. We heard about how venture funds work with biotech to help great science to the clinic + helpful advice for anyone interested in exploring the early stage commercial space! spotifyanchor-web.app.link/e/Re97S3OXILb
Looking forward to presenting interim results of PANNA-COTA, demonstrating how liquid biopsy🩸🧬 Guardant360 CDx facilitates patient-centric enrolment to early phase clinical trials via NECTA network, at upcoming Medical Oncology Group of Australia Annual Meeting; 14-16th August in Sydney.
Thanks Jenny Jia (Jenny) Liu for the update NECTA at #MOGA24 Medical Oncology Group of Australia Dr Deme Karikios Malinda Itchins ONCODOC Linda Mileshkin Liz Connolly Annie Wong 黃毅敏 Melissa Eastgate collaboration in action!
How can we grow paediatric clinical trials globally? This episode we tackle how the complexity in these patients and trials can be balanced with challenges of drug dev, and what new models could be adopted in the future. #paediatrics #oncology #trials podcasters.spotify.com/pod/show/necta…